RESEARCH Page 1 The use of pioglitazone and the risk of bladder cancer in people with
type 2 diabetes: nested case-control study OPEN ACCESS Laurent Azoulay assistant …

Background There is concern that antidiabetic incretin-based drugs, including dipeptidyl
peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues, can increase …

OBJECTIVE To determine whether glucagon-like peptide 1 receptor agonists (GLP-1 RA)
and sodium–glucose cotransporter 2 (SGLT-2) inhibitors, separately, are associated with a …

… Oriana Yu, Maria Eberg, Serge Benayoun, Armen Aprikian, Gerald Batist, Samy Suissa,
and Laurent Azoulay … sity; Gerald Batist and Laurent Azoulay, Segal Cancer Centre …

The prevalence of obesity, of type 2 diabetes mellitus (T2DM), and of cancer are all increasing
globally. The relationships between these diseases are complex, and thus difficult to …

Objective To determine whether the use of angiotensin converting enzyme inhibitors (ACEIs),
compared with use of angiotensin receptor blockers, is associated with an increased risk of …

Objective To assess whether the use of dipeptidyl peptidase-4 inhibitors is associated with
the incidence of inflammatory bowel disease in patients with type 2 diabetes. Design …

OBJECTIVE Time-related biases in observational studies of drug effects have been described
extensively in different therapeutic areas but less so in diabetes. Immortal time bias, time-…

Objectives To assess whether a double therapy combination consisting of diuretics,
angiotensin converting enzyme inhibitors, or angiotensin receptor blockers with addition of non-…

OBJECTIVE: Amniotic fluid embolism (AFE) is a condition occurring during delivery that can
lead to severe maternal morbidity and mortality. Given the rarity of its occurrence, current …